If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -3.00 (-0.64%)
Spread: 10.00 (2.174%)
Open: 465.00
High: 465.00
Low: 465.00
Prev. Close: 468.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

APEX stocks now trading on Hargreaves Lansdown

6 Jul 2022 12:00

RNS Number : 5325R
Aquis Exchange PLC
06 July 2022
 

 

RNS Reach

6th July 2022

Aquis Exchange PLC

("Aquis" or the "Group")

APEX stocks now available for electronic trading via Hargreaves Lansdown

 

AQSE is delighted to announce that for the first time in the exchange's history, APEX stocks are now available to trade electronically on the Hargreaves Lansdown trading platform, the UK's number one platform for private investors.

 

As the next-generation stock exchange continually pushing to reshape capital markets, we would like to thank Hargreaves Lansdown for their support and look forward to working closely with the team there to add our ACCESS stocks in due course. 

 

Commenting on the development, Aquis Exchange, CEO Alasdair Haynes, said:

 

"I am very pleased that Hargreaves Lansdown is now including certain AQSE shares for electronic trading on its platform. I know that there is much client demand for this and we are looking forward to the scheme being extended to cover many more AQSE stocks as soon as possible. It is vital for the public to be able to access the shares quoted on the UK's two stock exchanges easily, efficiently and, crucially, on an equal footing as each other."

 

Tom Lee, Head of Trading Proposition, Hargreaves Lansdown, said:

 

"As market leader, we continue to evolve and digitise our trading service and offering APEX stocks via an easy online experience reflects our ambitions to redefine the savings and investing experience for investors."

 

AQSE is home to over 100 securities and has welcomed 11 new companies to its growth market so far this year, with many more in the pipeline.  As a division of leading exchange services company, Aquis Exchange PLC, AQSE is a business underpinned by a robust regulatory framework, overseen by the FCA, and has a strong service culture.

 

For further information, please contact:

 

AQSE:

Andrea Lee / alee@aquis.eu +44(0) 7804241180

Jude Roberts / jroberts@aquis.eu +44(0) 20 3597 6384

 

Alma PR:

Susie Hudson / susie@almapr.co.uk +44(0) 7909 009 173Kieran Breheny / kieran@almapr.co.uk + +44(0) 7530 172 280

Lily Soares Smith / lily@almpr.co.uk +44(0) 7875 229 830

 

Notes to editors:

 

About Aquis Exchange PLC

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange PLC is quoted on the Aquis Stock Exchange and on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFIDDIRIIF
Date   Source Headline
26th May 20227:00 amRNSChange of registered address
29th Apr 20221:57 pmRNSDirector/PDMR Notification and Issue of Options
26th Apr 20223:05 pmRNSBoard Appointments
26th Apr 20222:59 pmRNSResult of AGM
4th Apr 20228:18 amRNSPublication of Annual Report and Notice of AGM
4th Apr 20227:00 amRNSDirector/PDMR Dealing
1st Apr 20223:53 pmRNSTransfer of UBS MTF Business Activities Completed
30th Mar 20229:35 amRNSExercise of Share Options and Total Voting Rights
29th Mar 20227:10 amRNSFinal Results and Board Appointments
29th Mar 20227:00 amRNSAdmission to Trading on the AQSE Growth Market
16th Mar 20227:00 amRNSTransfer of UBS MTF business activities to Aquis
11th Mar 20227:00 amRNSIntention to Dual List on the AQSE
24th Feb 20227:00 amRNSNotice of Results
8th Feb 20227:00 amRNSAquis Technologies partners with Investre
26th Nov 20219:48 amRNSExercise of Share Options and Total Voting Rights
26th Nov 20217:00 amRNSAppointment of New Chair
25th Nov 20217:00 amRNSDirector/PDMR Notification
23rd Sep 20215:39 pmRNSExercise of Share Options, Director Dealing & TVR
23rd Sep 20217:00 amRNSInterim Results
17th Sep 20217:00 amRNSBoard Appointment
1st Sep 20217:00 amRNSNotice of Results
25th Aug 20217:00 amRNSAppointment of independent NED to AQSE Board
2nd Aug 20217:00 amRNSAquis Exchange achieves record market share
28th Jun 20214:21 pmRNSExercise of Share Options and Director Dealing
27th May 20217:00 amRNSAQSE expands research for its top-tier stocks
18th May 20217:00 amRNSDual quotations with the Frankfurt Stock Exchange
13th May 20217:00 amRNSNew Senior Management Appointments
30th Apr 20217:00 amRNSDirector/PDMR Notification & Issue of Options
27th Apr 202112:41 pmRNSResult of Annual General Meeting
8th Apr 20217:00 amRNSDirector/PDMR Notification
31st Mar 20214:51 pmRNSPublication of ARA and Notice of AGM
31st Mar 20217:00 amRNSFinal Results
26th Mar 20217:00 amRNSNotice of Results
24th Mar 20217:00 amRNSAquis Exchange and ShareSoc Retail Investor Survey
26th Feb 20217:00 amRNSTrading and Operational Update
5th Feb 202112:07 pmRNSAppointment of Joint Broker
4th Feb 20218:03 amRNSAquis Exchange recommences trading in Swiss shares
14th Dec 20207:00 amRNSAQSE rule changes & market segments now in effect
26th Nov 20207:00 amRNSDirector/PDMR Notification
23rd Nov 20207:00 amRNSAQSE launches Market Maker Incentive Scheme
20th Nov 20202:00 pmRNSAquis works with SGX & AWS on cloud deployment
19th Oct 20207:00 amRNSAppointment to the AQSE Board
12th Oct 20207:00 amRNSAppointment of Independent Non-executive Director
9th Sep 20207:00 amRNSInterim Results
27th Aug 20207:00 amRNSNotice of Results
17th Jun 20207:00 amRNSBoard Appointment
16th Jun 20207:00 amRNSHolding(s) in Company
15th Jun 20207:01 amRNSDirector/PDMR Notification
15th Jun 20207:00 amRNSIssue of Options and Director/PDMR Notification
19th May 20201:26 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.